Version-4 (Jan-Feb 2014)
Version 1 Version 2 Version 3 Version 4 Version 5 Version 6
- Citation
- Abstract
- Full PDF
Abstract: The purpose of this effort is to provide an introduction and overview of the process validation of the production of pharmaceutical manufacturing process especially tablet with particular attention to the U.S. Food and Drug Administration requirements (FDA). Quality is always a prerequisite when looking at a product. Therefore, drugs must be manufactured to the highest quality standards. In the context of one of the types of process validation, retrospective validation are used for the facilities , processes and process controls in use that have not been subjected to a documented formal process validation (prospective, concurrent ) . The validation of these facilities , processes and process controls can use historical data to provide the necessary evidence that the process does what it is supposed to do provide the source of data for this study include , but are not limited to processing batch records and packing , process control charts , logs, maintenance records personnel changes , process capability studies , final data, including trend cards and storage stability validation results. Retrospective validation is the starting point for the non-regulated or Sami-regulated toward the compliance of cGMP and is less expensive exercise to evaluate and demonstrate the product quality. Application of statistical and quality control will give a strength, confidence and reliability to demonstrate the retrospective process validation.
Keywords: Retrospective, Statistical Tool, Quality Control Tool, Validation, Process Validation.
[1] Guidance for Industry: Process Validation: General Principles and Practices. U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), Centre for Veterinary Medicine (CVM), January 2011.
[2] Md. Shoaib Alam, Pharmaceutical Process Validation, an Overview, Journal of Advanced Pharmacy Education & Research Oct-Dec 2012 Vol 2 Issue 4.
[3] PIC/S Guide to good manufacturing practice for medicinal product, PE 009-10(annexes) Annex 15, 1 Jan 2013.
[4] Md. Shoaib Alam, Pharmaceutical Process Validation, an Overview, Journal of Advanced Pharmacy Education & Research Oct-Dec 2012 Vol 2 Issue 4.
[5] Keith M. Bower, M.S Process Capability Analysis Using MINITAB.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Trial Design: Observational study
Methods
Inclusion criteria: All In-patients who were treated with AEDs admitted in different units of Medicine Department.
Exclusion Criteria: All pregnant women who are on AEDs.
Sample size: 35
Objective: The chief objective behind this project was to observe the various therapy of AED used in epilepsy and in some co-morbid condition and to observe the patient condition.
Outcome
A total of 35 patients data were recorded in the study for 1 month.
In the study percentage of men suffering from epilepsy was 45.71% (16) and Female was 54.24 %( 19).
The study shows that most of the patients 14 (40%) were from the age group of 31-60 years; followed by 14 (40%) of patients in the age group of 61-90 years and 7 (20%) patients were in the group of 10-30 year.
Most commonly prescribed drug concluded is phenytoin which accounts for 30 (85.30%) in both the genders, followed by phenobarbitone 11 (31.18%) and levitracetam usage was 11 (31.18%)
Monotherapy is the type of therapy most frequently used in 23 patients (65.71%).
Dual therapy is used in 6 patient (17.14%).Triple therapy is used in 5 patient (14.28%).
Conclusion: The most frequently prescribed AED in the study was Phenytoin followed by Phenobarbital and levitracetam.
[1]. Dhillon S, Sander JW. Epilepsy. In: Walker R, Edwards C, editor. Clinical Pharmacy and Therapeutics. 3 ed. Scotland: Churchill living stone; 2003; 465-466.
[2]. Helms, Quan, Herfindal, Gourley. Textbook of therapeutics drug and disease management 8th ed., pg. nos. 1609, 1611.
[3]. Sridharan R., Epidemiology of Epilepsy, Current Sciences, Vol. 82, No. 6, 2002 March 25th, pg. nos. 664-670.
[4]. Arulkumaran K.S.G. et al., A study on the drug use evaluation of ADEs at multispecialty Tertiary Care Teaching Hospital. International Journal of Pharm. Tech. Research Coden (USA), Vol. 1 (4), 2009 Oct-Dec, pg. nos. 1541-1547.
[5]. Sato, S., Clin. Neurol. (Tokyo), 1964, Vol. 4, pg. nos. 313-324.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: The present study was undertaken with the aim to find prevalence of biofilm forming ability among Pseudomonas aeruginosa clinical isolates. A total of 129 clinical isolates were identified from clinical specimens by standard microbiological techniques. Biofilm formation ability among these isolates was studied using in vitro bifilm formation assay. Minimum inhibitory concentration (MIC) and minimum biofilm eradication concentration (MBEC) were studied using procedure as described in Clinical and Laboratory Standards Institute. Among 129 isolates, the prevalence of aminoglycoside resistance was 75.2 % out of which 70.1% were found to be biofilm producers. The MIC for Tobracef in aminoglycoside resistant strains ranged from 8 to 16 μg/ml and for other antibacterial drugs it ranged from 16 to 256 μg/ml. The MBEC for Tobracef in biofilm producing isolates was ranged from 32 to 64 μg/ml and for other antibacterial agents, it ranged from 1024 to 8292 μg/ml. When the effect of half of MBEC of drugs were evaluated on preformed biofilms, Tobracef significantly reduced viable counts of bacterial cells presented in biofilms of P. aeruginosa with log reduction values ranging 5.17 to 5.46 logs. Our data showed that Tobracef has significantlly enhanced activity against aminoglycoside resistance biofilm producing isolates. Therefore, use of this antibiotic should be considered to treat the infections caused by aminoglycoside resistant biofilm producing isolates.
Keywords: Bifilm, Clinical isolate, MIC, MBEC,Tobracef.
[3] D.M. Ramsey, and D.J. Wozniak,Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Molecular Microbiology, 56, 2005, 309–322.
[4] N. Hoiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu, Antibiotic resistance of bacterial biofilms. International Journal of Antimicrobial Agents 35, 2010, 322–332.
[5] D.S. Blanc, C. Petignat, B. Janin, J. Bille, and P. Francioli, Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clinical Microbiology and Infection, 4, 1998, 242–247.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Acinetobacter baumannii, pili, hemagglutinin, adhesin protein, s-IgA.
[2]. Brooks GF, Butel JS, Morse SA. 2004. Pseudomonads, Acinetobacters, dan uncommon Gram-negative Bacteria. In: Jawetz, Melnick, and Adelberg's Medical Microbiology. 23th Ed. San Francisco : A Lange medical Book. pp. 262-68.
[3]. Peleg A.Y, Seifert H, and Paterson D.L. 2008. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. 21(3): 538-82.
[4]. Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, and Villari P. 2004. Molecular Epidemiology of Sequential Outbreaks of Acinetobacter baumannii in an Intensive Care Unit Shows the Emergence of Carbapenem Resistance. Journal of clinical microbiology. 42(3): 946–53.
[5]. Holmes B and Howard BJ, 1994. Nonfermentative Gram-Negative Bacteria. In: Clinical and Pathogenic Microbiology, 2nd ed. Howard BJ et al (ed.), St. Louis, Washington DC, Toronto: CV Mosby Co, pp.337-64.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: chicken, feed, microbial, processing, spent sorghum grains.
[2] E. A. Iyayi and Z. A. Aderolu,. Enhancement of the feeding value of some agro-industrial by-products for laying hens after their solid state fermentation with Trichoderma viride, African Journal of Biotechnology, 3 (3), 2004, 182-185.
[3] J. P. Essien, I. R. Udotong, M. Bassey, and N. Asamudo, Bioconversion of brewers spent grains for possible use as poultry feed, World Journal of Applied Science and Technology, 2010, 2(2), 197 - 203
[4] K. H. Domsch, W. Gam, and T. Anderson, Compendium of soil fungi ( London: Academic Press Limited, 1980).
[5] R. A. Samson, E. S. Hoekstra and C. A. N. Van Oorschot, Introduction to food–borne fungi (Netherlands: Institute of the Royal Netherlands Academy of Arts and Sciences, 1984).
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Glimepiride, Metformin HCL, Oral controlled release drug delivery system, HPMC.
[1]. James.Swarbrick. Encyclopedia of pharmaceutical technology, 3rd ed., (2): 1082 (2007).
[2]. www.ondrug delivery.com/Oral_drug_delivery.
[3]. Kewal.K.Jain. Method in molecular biology 437. Drug delivery system. 217 (2008).
[4]. D M Brahmankar and Sunil B Jaiswal, Biopharmaceutics and pharmacokinetics. A treatise, VallabhPrakashan. 2nd ed., 406 (2009).
[5]. Rajan K. Verma and Sanjay Garg. Current status of drug delivery technologies and future directions, Pharmaceutical technology on-line. 25 (2): 1–14 (2001).
- Citation
- Abstract
- Reference
- Full PDF
Key words: Glycolipids, leaf development, phospholipids, Rauwolfia serpentina, senescence, sterol.
[1]. BenRais L, Alpha MJ, Bhal J (1993) Lipid and protein contents of jojoba leaves in relation to salt adaptation. Plant Physiol. 31:547557.
[2]. Bhatara VS, Sharma JN, Gupta S, Gupta YK. Images in psychiatry. Rauwolfia serpentina: the first herbal antipsychotic. Am J Psychiatry 1997: 154(7): 894.
[3]. Brown JH, Lynch DV, Thompson JE (1987) Molecular species specificity of phospholipids breakdown in microsomal membrane of senescing carnation flowers. Plant Physiol. 85:679683.
[4]. Canel C, LopesCardoso MI, Whitmer S, van der Fits L, Pasquali G, van der Heijden R, Hoge JH, Verpoorte R (1998) Effects of overproduction of strictosidine synthase and tryptophan decarboxylase on alkaloid production by cell cultures of Catharanthus roseus. Planta 205:4419.
[5]. Chia LS, Thompson JE, Dumbroff EB (1981) Simulation of the effect of leaf senescence on membrane by treatment with paraquat. Plant Physiol. 67:415-420.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Acinetobacter calcoaceticus, Ganoderma lucidum, Catalase, Biosensor, Milk and calcium.
[2]. Alzamora, S. M., Salvatori, D., Tapia, M. S., Lopez-Malo, A., Welti-Chanes, J., & Fito, P. (2005). Novel functional foods from vegetable matrices impregnated with biologically active compounds. Journal of Food Engineering, 67, 205–214.
[3]. Caceres, E., Garcia, M. L., & Selgas, M. D. (2006). Design of a new cooked meat sausage enriched with calcium. Meat Science, 73, 368–377.
[4]. Kamal, T. H. (1960). Complexometric titration of calcium and magnesium in the presence of phosphate in milk and blood plasma. Journal of Agricultural and Food Chemistry, 8, 156–158.
[5]. Manganaris, G. A., Vasilakakis, M., Diamantidis, G., & Mignani, I. (2007). The effect of postharvest calcium application on tissue calcium concentration, quality attributes incidence of flesh browning and cell wall physicochemical aspects of peach fruits. Food Chemistry, 4, 1385-1392.
- Citation
- Abstract
- Reference
- Full PDF
Key words: external attributes, detached, 16SrDNA scrutiny, species level.
[2]. Anonymous. (1957).Manual of Microbiological Methods. McGraw Hill Book Company Inc. New York. p.127.
[3]. Anonymous. (2010). "Universal bacterial Identification by PCR and DNA sequencing of 16SrRNA gene".PCR for Clinical Microbiology.Part3:209-214.
[4]. Cappuccino, J.G.and Sherman, N. (2005).Microbiology: A Laboratory Manual.7th edition. The Pearson Education. Darling Kindersley (Ind) Pvt.
[5]. Dubey, R.C. and. Maheshwari, D.K. (2002).A Textbook of Practical Microbiology.S.Chand Co.Ltd, Ram Nagar.Newdelhi.p.352.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Jamboni Block, NTFPs, Ethnobotany, Marketing, Sustainable management.
[1] Ghosh, P. Studies on some ethno-botanically important plants of Jhargram Block, West Midnapore, West Benngal, Indian J. Applied & Pure Bio. 27(2), 2012, 195-197.
[2] Jain S K. Dynamics of Traditional Knowledge, Indian J. Trad. Knowledge, 4(2), 2005, 115-117.
[3] Jain, S K. Ethnobotany in India: some thought on future work, Ethnobotany, 22, 2010, 1-4.
[4] Jain, S K. Ethnobotany-Good, bad and Path-breaking! Ethnobotany, 24 (1&2), 2012, 1-3
[5] Roy S B. Bilateral Matching Institution: An illustration in Forest Conservation, The Journal of Indian Anthropological Society of India, 27, 1992, 253-262.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Process validation, Quality tools, Statistical techniques, Content Uniformity, Process capabilities.
[2] Robert A .Nash , Alferd H. Watcher Pharmaceutical process validation 3rd edition Volume 129
[3] Graph prism pad Version 5
[4] M.G Natrella Experimental statistics (Hand book 91. US Government printing office ,Washington DC. 1963
[5] Box, G. E. P., Gunter, W. G., and Hunter, J. S. Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. New York: Wiley (1978).
- Citation
- Abstract
- Reference
- Full PDF
Paper Type | : | Research Paper |
Title | : | Process and Productivity Improvement |
Country | : | Pakistan |
Authors | : | Syed Muhammad Ali Zaidi |
: | 10.9790/3008-09147578 |
Keywords: Blister, Granulation, Production Orders, Scrape Factor, SPC.
[1] Rajkumar P. Patil, Shakthi Prakash M R, Productivity Enhancement and Measurement in Pharmaceutical Industry, International Journal of Pharma. Research & Development, IJPRD/2011/PUB/ARTI/VOV-3/ISSUE-1/MARCH/018
[2] John Dramm, Results-Driven Approach to Improving Quality and Productivity.
[3] Donna Knight, How to Improve Pharmaceutical Productivity. Available from: http://www.ehow.com/how_6982231_imporve-pharmaceutical productivity.html#ixzz19OqcJgqQ.
[4] Aftab Ahmed, Imtiyaz Khan & M.K. Ghosh, SPC Implementation in Pharmaceutical Industry for Material Flow Management, Interscience Management Review (IMR), ISSN: 2231-1513, Volume- 2, Issue-3, 2012.
[5] Jay Heizer and Barry Render, Sugar Confectionery Manufacture (1999) by E. B., "Operational Management", Tenth Edition, Jackson, chapter 11.
- Citation
- Abstract
- Reference
- Full PDF
[2]. Renault D, Deniel F, Benizri F, Sohier D, Barbier G,Rey P.Characterization of Bacillus and pseudomonas strains with suppressive traits isolated from tomato hydroponic-slow filtration unit. Can J Microbial.2007;53:784-97.
[3]. Uchino M, Shida O,Uchimura T, Komagata k.Recharacterization of Pseudomonas fulva lizuka and Komagata 1963,and proposals Pseudomonas parafulva sp. nov. and Pseudomonas cremoricolorata sp.nov.J Gen Appl Microbial. 2001;47:247-261.
[4]. Post RL, Kume S.Evidence for an aspartyl phosphate residue at the active site of sodium and potassium ion transport adenosine triphosphate.J Biol Chem. 1973; 248:6993-7000.
[5]. V Weiss,B Magasanik.Phosphorylation of nitrogen regulator I (NRI) of Escherichia coli.Proc Natl Acad Sci U S A. 1988;85:8919-8923.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Essential oil, antibacterial activity, MIC, antioxidant activity and synergistic activity.
[2]. Alzoreky, N.S. and Nakahara, K. 2003. Antibacterial activity of extracts from some edible plants commonly consumed in Asia. International Journal of Food Microbiology 80: 223–230.
[3]. Kumar, S., Narain, U., Tripathi, S. and Misra, K. 2001. Syntheses of curcumin bioconjugates and study of their antibacterial activities against β-lactamase-producing microorganisms. Bioconjugate Chemistry 12: 464–469.
[4]. Kumarasamy, Y., Cox, P., Jaspars, M., Nahar, L. and Sarker, S. 2002. Screening seeds of Scottish plants for antibacterial activity. Journal of Ethnopharmacology 83: 73–77.
[5]. Gulluce, M., Sokmen, M.; Deferera, D., Agar, G., Ozkan, H., Kartal, N., Polissiou, M., Sokmen, A. and Sahin, F. 2003. In vitro antibacterial, antifungal, and antioxidant activities of the essential oil and methanol extracts of herbal parts and cullus cultures of Satureja hortensis L. Journal of Agricultural and Food Chemistry 51: 3958-3965.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: FMEA , HACCP ICH Pharmaceutical Industry, Quality Risk Management, Risk Assessment, Risk Control, Risk Identification, WHO. Gezt Pharma.
[1] http://www.ich.org/products/guidelines/quality/article/qualityguidelines.html
[2] http://www.ich.org/products/guidelines/quality/q9-briefing-pack.html
[3] http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Q9_Briefing_Pack/Tools_-_Applications.pdf
[4] http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf
[5] http://apps.who.int/prequal/info_general/documents/TRS961/TRS961_Annex7.pdf
- Citation
- Abstract
- Reference
- Full PDF
Keywords: Angle of Repose, Bulk Density, Flowability, Tapped Density, Thick Extract.
[2] Charu V. Navaneethan, Shahrzad Missaghi, and Reza Fassihi, AAPS PharmSciTech. 6(3): E398–E404.
[3] Rakhi B. Shah, Mobin A. Tawakkul, and Mansoor A. Khan, AAPS PharmSciTech. 2008 March; 9(1): 250–258.
[4] AbdulMobeen Faqih, Bodhisattwa Chaudhuri, Fernando J. Muzzio, M. Silvina Tomassone, Albert Alexander, Steve Hammond,
Volume 52, Issue 12, pages 4124–4132, December 2006
[5] T. Dyakowski, S.P. Luke, K.L. Ostrowski, R.A. Williams, Volume 104, Issue 3, October 1999, Pages 287–295.
- Citation
- Abstract
- Reference
- Full PDF
Keywords: C57BL/6J, Metabolic Syndrome, High Fat Simple Carbohydrate (HFSC) Diet.
[2] F. Amanda, C. Leone, and T. Steve. The Prevalence of Metabolic Syndrome in Children:A Systematic Review of the Literature, Metabolic Syndrome And Related Disorders, 2013,11(2), 71-80.
[3] U. O. Charles and G. O. Emeka. Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients, Indian Journal of Endocrinology and Metabolism , 2012 ,16(1),S104-109.
[4] D. Ankhush and T. Nikhil. Challenges in prevention and management of diabetes mellitus and metabolic syndrome in India, Current Science, 2009; 97: 356-366.
[5] K. Shiwaku , A. Nogi, K. Kitajima, E. Anuurad, B. Enkhmaa, M. Yamasaki, J.-M. Kim, I.-S. Kim, S.- K. Lee, T. Oyunsuren and Y. Yamane. Prevalence of the Metabolic Syndrome using the modified ATP III definitions for workers in Japan , Korea and Mongolia, Journal of Occupational Health, 2005,47,126-135.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: A simple, selective and precise RP-HPLC method was developed for the simultaneous estimation of Aliskiren Hemifumarate, amlodipine besylate and hydrochlorothiazide in the Bulk and Pharmaceutical Dosage Forms using losartan as an internal standard. The chromatographic separation of the three drugs was achieved on a reverse phase Inertsil-ODS, C18, 100X 4.6 mm, 5μm column using 0.1 M Ammonium acetate buffer (pH adjusted to 5 using formic acid) and Acetonitrile in the ratio of 65:35 v/v with flow rate of 1.0 ml/min with injection volume 20 μL and the detection was carried out at 232 nm. The retention time of aliskiren hemifumarate (ALSK), amlodipine besylate (AMLO) and hydrochlorothiazide (HCT) were found to be 3.90, 5.22 and 1.91 min respectively. The drug products were subjected to stress conditions of acidic, alkaline, oxidation, UV and Thermal conditions. The degradation products were well resolved from ALSK, AMLO and HCT peaks, thus indicating the stability-indicating nature of the method. The linear regression analysis data for the calibration plots showed good linear relationship in the concentration range of 37.5-225.00 μg/ml for aliskiren hemifumarate, 3.125-18.75 μg/ml for hydrochlorothiazide and 1.25-7.50 μg/ml for amlodipine besylate. The developed method was successfully validated in accordance to ICH guidelines. Hence, this method can be conveniently adopted for the routine analysis in quality control laboratories.
Key words: Aliskiren hemifumarate, Amlodipine besylate, Hydrochlorothiazide, RP-HPLC
[2] Feng Gao, Mengliang Zhang, Xiangyong Cui, Zhonghua Wang, Yantong Sun, Jingkai Gu. Simultaneous quantitation of hydrochlorothiazide and metoprolol in human plasma by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 52 (2010) 149–154
[3] Palak V.Chokshi*,Karan J.Trivedi, Nishit S.Patel Development And Validation Of RP-HPLC Method For Analysis Of Aliskiren Hemifumarate And Valsartan In their Combination Tablet Dosage Form International Journal of ChemTech Research Vol.4, No.4, pg 1623-1627
[4] Micheli Wrasse-Sangoi, Leonardo Trevisan Secretti. Development and validation of an UV spectrophotometric method for the determination of aliskiren in tablets. Isabel Fração Diefenbach e Clarice Madalena Bueno Rolim. Quim. Nova, Vol. 33, No. 6, 1330-1334, 2010.
[5] Richa Sah* and Saahil Arora. Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca+2 channel blocker. Journal of Advanced Pharmacy Education & Research 2 (3) 93-100 (2012).
- Citation
- Abstract
- Reference
- Full PDF
Key words: Metformin Hydrochloride, Pioglitazone Hydrochloride, Glibenclamide, RP-HPLC.
[2] Chaturvedi RSPK(2008) Simultaneous spectrophotometric estimation and validation of three component tablet formulation containing pioglitazone hcl, metformin hcl and glibenclamide Analytical Letters 12:2133-2142
[3] Kishore L, Kaur N (2011) Estimation of pioglitazone and glimepiride in its pharmaceutical dosage form by spectrophotometric methods.Der Pharmacia Lettre 4:276-284
[4] Sane T, Menon N, Shafi I, Mandar M, Ajay M. Simultaneousdetermination of pioglitazone and glimepiride by high-performance thinlayerchromatography, J. Planar Chromatogr., 2004; 17: 154-156
[5] Zhong WZ, Lakings DB. Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquidchromatography with ultraviolet (229 nm) detection. J. Chromatogr. 1989; 490: 377-385.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Hepatitis B virus infection (HBV) is common among prisoners suggesting them as one of the main infection source in the community; Hence in this study, we evaluated the sero-prevalence of this infection among jail inmates in Bali prison, Taraba State Nigeria between August and November 2013. The sero-prevalence of Hepatitis B among the random population of sentenced prison inmates was investigated. We examined a total of fifty (50) inmates (49 males and 1 female). All collected blood samples were tested for Hepatitis B surface Antigen antibodies using rapid test strip (Global). An overall prevalence rate of 18% ( 9 positive inmates) was observed. Male inmates were mostly infected while the only female inmate was not. Inmates between the age group 20 – 29 years had higher infection rate. There was significant association (p<0.01) between age, sex and HBsAg sero-positivity in this study. This study confirms the presence of HBsAg among jailed inmates in Bali prison. Regular testing for hepatitis B virus antibodies in prisons is necessary to identify those already infected and those in need of specific health care to help limit further transmission of the disease within and outside the prison. Furthermore, introduction of effective preventive measures is recommended and uninfected inmates should be vaccinated as this will reduce the spread of the disease.
Key words: Inmates, HBsAg, Bali prison, Survey, Sero-positivity.
[2]. E.A. Alikor and O.N. Erhabor, Sero-prevalence of hepatitis B surface antigenamia in children in a tertiary health institution in the Niger Delta of Nigeria. Nigerian Journalof medicine, 16(3), 2007,250-1.
[3]. J. Amin, H. Yousuf, A. Mumtaz, M. Iqbal, R. Abmed, S Z. Adhami, and K Malik, Prevalence of Hepatitis B surface Antigen and anti-hepatitis C virus. professional medical Journal,11, 2004334.
[4]. Anonymous, Centres for Disease Control and Prevention. Transmission of hepatitis B virus in correctional facilities.2004, Georgia, 1999-2002. MMWR, 53(30),678-81.
[5]. S. Aziz, A A. Memon, H I. Tily, K. Rashed, K. Jehangir, Prevalence of HIV, Hepatitis B and C among Health workers of civil Hospital, Karachi,Journal of Pakistan medical association, 52 (3) 2002, 92.
- Citation
- Abstract
- Reference
- Full PDF
[2]. Abdelwahab S.F., Hashem M., Galal I., Sobhy M., Abdel-Ghaffar T.S., Galal G., Mikhail N., El-Kamary S.S., Waked I. and Strickland G.T. (2013). Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection. J Clin. Virol. 57 (1): 24-8.
[3]. Friebe P. and Bartenschlager R. (2002). Genetic analysis of sequences in the 3′ non-translated region of hepatitis C virus that are important for RNA replication. J. Virol. 76: 5326 – 38.
[4]. Yi M. and Lemon S. M. (2003). Structure–function analysis of the 3′ stem-loop of hepatitis C virus genomic RNA and its role in viral RNA replication. RNA, 9: 331– 45.
[5]. Bartenschlager R. and Lohmann V. (2000). Replication of hepatitis C virus. J. Gen. Virol. 81: 1631– 48.